A team of scientists from the Institute of Bio- and Geosciences–Biotechnology at Forschungszentrum Jülich worked together with the company Novonesis to develop a bacterium that "eats" individual ...

"Our AI-powered platform is designed with the goal of transforming the IPO process by making it more efficient and accessible," said Edward C. Lee, CEO of Hestia Insight Inc. Mr. Lee continued, "This ...

BioSkryb Genomics, a Durham company focused on single-cell and ultra-low input multiomics, has introduced a new service called ResolveSEQ MRD, which allows more detailed classification and ...

Protein Expression Technology MarketThe global protein expression technology market is set for significant expansion, ...

Thank you for standing by, and welcome to the Origin Agritech Fiscal Year 2024 Conference Call. Please note that, today's call is being recorded. It is now my pleasure to introduce Matthew Abenante of ...

Tevogen Bio remains steadfast in its mission to pioneer accessible and affordable precision medicine while advocating for fair and transparent market participation.

A group of researchers from the Institute of Bio- and Geosciences – Biotechnology at Forschungszentrum Jülich, in collaboration with the company Novonesis, has successfully engineered a bacterium ...

As the global population continues to grow, innovative solutions are needed to ensure food security. With limited land and ...

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) stock has reached a new 52-week low, touching down at $30.86, with InvestingPro data showing the stock trading at $30.89, significantly below its 52-week high ...

A new study explores how complex chemical mixtures change under shifting environmental conditions, shedding light on the ...